Prolonged Survival of Patients With Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era-Reference-Cited by-同舟云学术

Prolonged Survival of Patients With Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era

Published:2014-05 Issue:3 Volume:15 Page:202-206
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Riess Jonathan W.,Nagpal Seema,Iv Michael,Zeineh Michael,Gubens Matthew A.,Ramchandran Kavitha,Neal Joel W.,Wakelee Heather A.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference21 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced non-small-cell lung cancer: clinical implications for the subsequent management of the brain;Chen;Cancer,2007

3. EGFR mutation status and survival after diagnosis of brain metastasis in non-small cell lung cancer;Eichler;Neuro Oncol,2010

4. Morris PG, Reiner AS, Szenberg OR, et al. Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy [published online November 15, 2011]. J Thorac Oncol.

5. Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era;Park;Lung Cancer,2012

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal pemetrexed in patients with EGFR-TKI resistant refractory leptomeningeal metastasis lung adenocarcinoma : a retrospective study;2023-12-06

2. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment;International Journal of Molecular Sciences;2023-07-14

3. Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases;Translational Oncology;2023-05

4. Intrathecal chemotherapy combined with systemic therapy in patients with refractory leptomeningeal metastasis of non-small cell lung cancer: a retrospective study;BMC Cancer;2023-04-11

5. Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases;Cancers;2023-03-21